Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo

Journal of Immunology

Volumn 173, Issue 12, 2004, Pages 7584-7593

  Brown, Nathaniel J ^a   Hutcheson, Jack ^a   Bickel, Emily ^a   Scatizzi, John C ^a   Albee, Lee D ^a   Haines III, G Kenneth ^b   Eslick, Joy ^a   Bradley, Kathleen ^a   Taricone, Elsa ^a   Perlman, Harris ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHEMOKINE; COLONY STIMULATING FACTOR 1; FAS ANTIGEN; FAS DEATH RECEPTOR; FAS LIGAND; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MALE; MONOCYTE; MOUSE; MOUSE STRAIN; MYELOID PROGENITOR CELL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 10344262904     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.12.7584     Document Type: Article

References (56)

1. Stoy, N. 2001. Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis. Pathobiology 69:179.
2. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965.
3. Perlman, H., L. J. Pagliari, N. Nguyen, H. Liu, and R. M. Pope. 2001. The Fas-FasL death receptor and PI3K pathways independently regulate monocyte homeostasis. Eur. J. Immunol. 31:2421.
4. Kiener, P. A., P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185:1511.
5. Kiener, P. A., P. M. Davis, B. M. Rankin, S. J. Klebanoff, J. A. Ledbetter, G. C. Starling, and W. C. Liles. 1997. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159:1594.
6. Brown, S. B., and J. Savill. 1999. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis in bystander leukocytes. J. Immunol. 162:480.
7. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, and L. D. Shultz. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442.
8. Takahashi, K., M. Naito, L. D. Shultz, S. Hayashi, and S. Nishikawa. 1993. Differentiation of dendritic cell populations in macrophage colony-stimulating factor-deficient mice homozygous for the osteopetrosis (op) mutation. J. Leukocyte Biol. 53:19.
9. Witmer-Pack, M. D., D. A. Hughes, G. Schuler, L. Lawson, A. McWilliam, K. Inaba, R. M. Steinman, and S. Gordon. 1993. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104:1021.
10. Naito, M., S. Hayashi, H. Yoshida, S. Nishikawa, L. D. Shultz, and K. Takahashi. 1991. Abnormal differentiation of tissue macrophage populations in Osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am. J. Pathol. 139:657.
11. Naito, M., S. Umeda, K. Takahashi, and L. D. Shultz. 1997. Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol. Reprod. Dev. 46:85.
12. Wiktor-Jedrzejczak, W., M. Z. Ratajczak, A. Ptasznik, K. W. Sell, A. Ahmed-Ansari, and W. Ostertag. 1992. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp. Hematol. 20:1004.
13. Wiktor-Jedrzejczak, W. W., A. Ahmed, C. Szczylik, and R. R. Skelly. 1982. Hematological characterization of congenital osteopetrosis in op/op mouse: possible mechanism for abnormal macrophage differentiation. J. Exp. Med. 156:1516.
14. Begg, S. K., J. M. Radley, J. W. Pollard, O. T. Chisholm, E. R. Stanley, and I. Bertoncello. 1993. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177:237.
15. Lagasse, E., and I. L. Weissman. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021.
16. Dai, X. M., G. R. Ryan, A. J. Hapel, M. G. Dominguez, R. G. Russell, S. Kapp, V. Sylvestre, and E. R. Stanley. 2002. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99:111.
17. Wiktor-Jedrzejczak, W., and S. Gordon. 1996. Cytokine regulation of the macrophage (Mφ) system studied using the colony stimulating factor-1-deficient op/op mouse. Physiol. Rev. 76:927.
18. Becker, S., M. K. Warren, and S. Haskill. 1987. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J. Immunol. 139:3703.
19. Kelley, T. W., M. M. Graham, A. I. Doseff, R. W. Pomerantz, S. M. Lau, M. C. Ostrowski, T. F. Franke, and C. B. Marsh. 1999. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J. Biol. Chem. 274:26393.
20. Munn, D. H., A. C. Beall, D. Song, R. W. Wrenn, and D. C. Throckmorton. 1995. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon γ. J. Exp. Med. 181:127.
21. Pope, R. M., and H. Perlman. 2000. Rheumatoid arthritis. In Current Molecular Medicine: Principles of Molecular Rheumatology. G. C. Tsokos, ed. Humana Press, Totowa, p. 325.
22. Mulherin, D., O. Fitzgerald, and B. Bresnihan. 1996. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39:115.
23. Smeets, T. J., M. C. Kraan, M. E. van Loon, and P. P. Tak. 2003. Tumor necrosis factor α blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum. 48:2155.
24. Nuki, G., B. Bresnihan, M. B. Bear, and D. McCabe. 2002. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 46:2838.
25. Genovese, M. C., J. M. Bathon, R. W. Martin, R. M. Fleischmann, J. R. Tesser, M. H. Schiff, E. C. Keystone, M. C. Wasko, L. W. Moreland, A. L. Weaver, et al. 2002. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 46:1443.
26. Perlman, H., L. J. Pagliari, H. Liu, A. E. Koch, G. K. Haines, and R. M. Pope. 2001. Rheumatoid arthritis synovial macrophages express FLICE-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum. 44:21.
27. Hashmioto, H., M. Tanaka, T. Suda, T. Tomita, K. Hayashida, E. Takeuchi, M. Kaneko, H. Takano, S. Nagata, and T. Ochi. 1998. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 41:657.
28. Lieschke, G. J., E. Stanley, D. Grail, G. Hodgson, V. Sinickas, J. A. Gall, R. A. Sinclair, and A. R. Dunn. 1994. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84:27.
29. 2-microglobulin. J. Immunol. 154:2063.
30. Perlman, H., H. Liu, C. Georganas, A. E. Koch, E. Shamiyeh, G. K. Haines, and R. M. Pope. 2001. Differential expression pattern of the anti-apoptotic proteins, Bcl-2 and Flip in experimental arthritis. Arthritis Rheum. 44:2899.
31. Perlman, H., K. Bradley, L. Hongtao, S. Cole, E. Shamiyeh, R. C. Smith, K. Walsh, S. Fiore, A. E. Koch, G. S. Firestein, et al. 2003. IL-6 and MMP-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J. Immunol. 170:838.
32. Perlman, H., C. Georganas, L. J. Pagliari, A. E. Koch, K. Haines, and R. M. Pope. 2000. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J. Immunol. 164:5227.
33. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71.
34. Leenen, P. J., M. F. de Bruijn, J. S. Voerman, P. A. Campbell, and W. van Ewijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174:5.
35. Schaller, E., A. J. Macfarlane, R. A. Rupee, S. Gordon, A. J. McKnight, and K. Pfeffer. 2002. Inactivation of the F4/80 glycoprotein in the mouse germ line. Mol. Cell. Biol. 22:8035.
36. Ratkay, L. G., B. Tait, J. Tonzetich, and J. D. Waterfield. 1994. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice. J. Autoimmun. 7:561.
37. Ji, H., D. Gauguier, K. Ohmura, A. Gonzalez, V. Duchatelle, P. Danoy, H. J. Garchon, C. Degott, M. Lathrop, C. Benoist, et al. 2001. Genetic influences on the end-stage effector phase of arthritis. J. Exp. Med. 194:321.
38. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system players. Immunity 16:157.
39. Ji, H., A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist. 2002. Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J. Exp. Med. 196:77.
40. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811.
41. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
42. Schneider, E., G. Moreau, A. Arnould, F. Vasseur, N. Khodabaccus, M. Dy, and S. Ezine. 1999. Increased fetal and extramedullary hematopoiesis in Fas-deficient C57BL/6-lpr/lpr mice. Blood 94:2613.
43. Traver, D., K. Akashi, I. L. Weissman, and E. Lagasse. 1998. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9:47.
44. lpr mice. J. Immunol. 173:4744.
45. Park, D. R., A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles. 2003. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170:6209.
46. Perlman, H., L. J. Pagliari, C. Georganas, T. Mano, K. Walsh, and R. M. Pope. 1999. Flice inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J. Exp. Med. 190:1679.
47. Bannerman, D. D., J. C. Tupper, J. D. Kelly, R. K. Winn, and J. M. Harlan. 2002. The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β. J. Clin. Invest. 109:419.
48. Hang, L., A. N. Theofilopoulos, and F. J. Dixon. 1982. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med. 155:1690.
49. Ito, M. R., S. Terasaki, J. Itoh, H. Katoh, S. Yonehara, and M. Nose. 1997. Rheumatic diseases in an MRL strain of mice with a deficit in the functional fas ligand. Arthritis Rheum. 40:1054.
50. Tu-Rapp, H., A. Hammermuller, E. Mix, H. Kreutzer, R. Goerlich, H. Kohler, H. Nizze, H. J. Thiesen, and S. M. Ibrahim. 2004. A pro-inflammatory role for Fas in joints of mice with collagen-induced arthritis. Arthritis Res. Ther. 6:R404.
51. Ma, Y., H. Liu, H. Tu-Rapp, H. J. Thiesen, S. M. Ibrahim, S. M. Cole, and R. M. Pope. 2004. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat. Immunol. 5:380.
52. Choe, J. Y., B. Crain, S. R. Wu, and M. Con. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J. Exp. Med. 197:537.
53. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
54. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, et al. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and erk signaling pathways. Curr. Biol. 10:640.
55. Kataoka, T., and J. Tschopp. 2004. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway. Mol. Cell. Biol. 24:2627.
56. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.